Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Long-term management of gout: nonpharmacologic and pharmacologic therapies.

Chaichian Y, Chohan S, Becker MA.

Rheum Dis Clin North Am. 2014 May;40(2):357-74. doi: 10.1016/j.rdc.2014.01.012. Epub 2014 Feb 20. Review.

PMID:
24703352
2.

[Gout: an overview of available urate lowering therapies].

Richette P.

Ann Pharm Fr. 2012 May;70(3):133-8. doi: 10.1016/j.pharma.2012.02.003. Epub 2012 Apr 27. Review. French.

PMID:
22655581
3.

Update on emerging urate-lowering therapies.

Chohan S, Becker MA.

Curr Opin Rheumatol. 2009 Mar;21(2):143-9. doi: 10.1097/BOR.0b013e328325bd94. Review. Erratum in: Curr Opin Rheumatol. 2010 Jan;22(1):106.

PMID:
19339925
4.

Advances in pharmacotherapy for the treatment of gout.

Robinson PC, Dalbeth N.

Expert Opin Pharmacother. 2015 Mar;16(4):533-46. doi: 10.1517/14656566.2015.997213. Epub 2014 Dec 30. Review.

PMID:
25547991
5.

Therapeutic approaches to chronic hyperuricemia and gout.

Grassi D, Pontremoli R, Bocale R, Ferri C, Desideri G.

High Blood Press Cardiovasc Prev. 2014 Dec;21(4):243-50. doi: 10.1007/s40292-014-0051-6. Epub 2014 Apr 3. Review.

PMID:
24696068
6.

Evaluation and treatment of gout as a chronic disease.

Perez-Ruiz F, Herrero-Beites AM.

Adv Ther. 2012 Nov;29(11):935-46. doi: 10.1007/s12325-012-0059-z. Epub 2012 Oct 25. Review. Erratum in: Adv Ther. 2012 Dec;29(12):1067. Dosage error in article text.

PMID:
23104464
7.

Major unanswered questions in the clinical gout field.

Stamp LK.

Curr Opin Rheumatol. 2017 Mar;29(2):171-177. doi: 10.1097/BOR.0000000000000367. Review.

PMID:
27926541
8.

Pegloticase for treating refractory chronic gout.

George RL Jr, Sundy JS.

Drugs Today (Barc). 2012 Jul;48(7):441-9. doi: 10.1358/dot.2012.48.7.1813475. Review.

PMID:
22844655
9.

New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.

Schlesinger N.

Curr Rheumatol Rep. 2010 Apr;12(2):130-4. doi: 10.1007/s11926-010-0093-2. Review.

PMID:
20425022
10.

Uricosuric medications for chronic gout.

Kydd AS, Seth R, Buchbinder R, Edwards CJ, Bombardier C.

Cochrane Database Syst Rev. 2014 Nov 14;(11):CD010457. doi: 10.1002/14651858.CD010457.pub2.

PMID:
25392987
11.

Allopurinol for chronic gout.

Seth R, Kydd AS, Buchbinder R, Bombardier C, Edwards CJ.

Cochrane Database Syst Rev. 2014 Oct 14;(10):CD006077. doi: 10.1002/14651858.CD006077.pub3. Review.

PMID:
25314636
12.

Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews.

Kydd AS, Seth R, Buchbinder R, Falzon L, Edwards CJ, van der Heijde DM, Bombardier C.

J Rheumatol Suppl. 2014 Sep;92:33-41. doi: 10.3899/jrheum.140460. Review.

PMID:
25180126
13.

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.

Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Herrero-Beites A, García-Erauskin G, Ruiz-Lucea E.

Ann Rheum Dis. 1998 Sep;57(9):545-9.

14.

[Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].

Fujimori S.

Nihon Rinsho. 2008 Apr;66(4):729-35. Review. Japanese.

PMID:
18409523
15.

Uricase and other novel agents for the management of patients with treatment-failure gout.

Sundy JS, Hershfield MS.

Curr Rheumatol Rep. 2007 Jun;9(3):258-64. Review.

PMID:
17531181
16.

Recent advances in management of gout.

Suresh E, Das P.

QJM. 2012 May;105(5):407-17. doi: 10.1093/qjmed/hcr242. Epub 2011 Dec 23. Review.

PMID:
22198943
17.

Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.

Becker MA, Schumacher HR, MacDonald PA, Lloyd E, Lademacher C.

J Rheumatol. 2009 Jun;36(6):1273-82. doi: 10.3899/jrheum.080814. Epub 2009 Mar 13.

PMID:
19286847
18.

Progress in the pharmacotherapy of gout.

Sundy JS.

Curr Opin Rheumatol. 2010 Mar;22(2):188-93. doi: 10.1097/BOR.0b013e3283369014. Review.

PMID:
20110792
19.

Management of hyperuricemia in gout: focus on febuxostat.

Reinders MK, Jansen TL.

Clin Interv Aging. 2010 Feb 2;5:7-18. Review.

20.

[Using the whole arsenal to prevent an attack].

Füeßl HS, Stiefelhagen P.

MMW Fortschr Med. 2015 Nov 19;157(20):22. German. No abstract available.

PMID:
26977497

Supplemental Content

Support Center